DOCSLIB.ORG

Oncogenic Transformation by the Jaagsiekte Sheep Retrovirus Envelope Protein

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oncogenic Transformation by the Jaagsiekte Sheep Retrovirus Envelope Protein Oncogene (2007) 26, 789–801 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein S-L Liu1 and AD Miller2 1Department of Microbiology and Immunology, McGill University, Montreal, Canada and 2Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Retroviruses have played profound roles in our under- sarcoma virus, both of which cause tumors in chickens standing of the genetic and molecular basis of cancer. (for a comprehensive review see Rosenberg and Jaagsiekte sheep retrovirus (JSRV) is a simple retrovirus Jolicoeur (1997)). Oncogenic retroviruses are historically that causes contagious lung tumors in sheep, known as classified into acute transforming retroviruses and ovine pulmonary adenocarcinoma (OPA). Intriguingly, nonacute retroviruses. Acute transforming retroviruses OPA resembles pulmonary adenocarcinoma in humans, induce tumors through acquisition and expression of and may provide a model for this frequent human cancer. cellular proto-oncogenes – a process referred to as Distinct from the classical mechanisms of retroviral oncogene capture. These retroviruses induce tumors oncogenesis by insertional activation of or virus capture rapidly, the tumors are of polyclonal origin, and the of host oncogenes, the native envelope (Env) structural viral oncogenes in these viruses are not essential for protein of JSRV is itself the active oncogene. A major virus replication. In fact, acute transforming retro- pathway for Env transformation involves interaction of viruses are often replication-defective (Rous sarcoma the Env cytoplasmic tail with as yet unidentified cellular virus is an exception) because of the loss or disruption of adaptor(s), leading to the activation of PI3K/Akt and essential viral genes during the oncogene capture MAPK signaling cascades. Another potential mechanism process. Nonacute retroviruses, on the other hand, do involves the cell-entry receptor for JSRV, Hyaluronidase not carry oncogenes and induce tumors slowly. This 2 (Hyal2), and the RON receptor tyrosine kinase, but the type of retrovirus causes tumors by activating cellular exact roles of these proteins in JSRV Env transformation proto-oncogenes close to the proviral DNA integration remain to be better understood. Recently, a mouse model sites – a process termed insertional activation. Nume- of lung cancer induced by JSRV Env has been developed, rous replication-competent retroviruses cause clonal and the tumors in mice resemble those seen in sheep tumors by proviral insertional activation. In addition infected with JSRV and in humans. In this review, we to oncogene capture and insertional activation, a few summarize recent progress in our understanding the replication-competent retroviruses induce tumors by molecular mechanisms of oncogenic transformation by expression of viral proteins. For example, human T-cells JSRV Env protein, and discuss the relevance to human leukemia virus types 1 and 2 (HTLV-1 and HTLV-2, lung cancer. respectively) induce adult T-cell immortalization and Oncogene (2007) 26, 789–801. doi:10.1038/sj.onc.1209850; leukemia in humans by expression of viral Tax proteins published online 14 August 2006 that transactivate several cytokines and cytokine recep- tors. It is worth noting that HTLV-1 and HTLV-2 are Keywords: Jaagsiekte sheep retrovirus; envelope pro- the only retroviruses identified so far, that directly cause tein; transformation; lung cancer; signaling pathways; human cancer. mouse model Jaagsiekte sheep retrovirus (JSRV) is simple retro- virus encoding Gag, Pro, Pol, and Env proteins (York et al., 1992; Palmarini et al., 1999; DeMartini et al., 2001), and is now classified as an ovine betaretrovirus. Sheep retroviral oncogenesis: a historical perspective This family also includes a closely related retrovirus of sheep and goats, enzootic nasal tumor virus (ENTV) For almost a hundred years, retroviruses have been (De las Heras et al., 2003). JSRV transforms peripheral known to induce tumors. The field started with the lung epithelial cells leading to ovine pulmonary adeno- discovery of avian erythroblastosis virus and Rous carcinoma (OPA) (Palmarini et al., 1999; DeMartini et al., 2001), while ENTV transforms nasal epithelial cells resulting in enzootic nasal tumor (ENT) (De las Correspondence: Professor S-L Liu, Department of Microbiology and Heras et al., 2003). OPA is a significant veterinary and Immunology, McGill University, 3775University Street, Lyman Duff economic problem in many countries, and in some Building Room 608, Montreal, QC Canada H3A 2B4. E-mail: [email protected] countries such as Britain and South Africa, the incidence Received 12 May 2006; revised 22 June 2006; accepted 24 June 2006; of OPA can be as high as 30% (Sharp and Angus, 1990). published online 14 August 2006 The clinical signs of OPA are associated with respiratory Oncogenesis by the JSRV envelope protein S-L Liu and AD Miller 790 dysfunction and include exaggerated breathing after JSRV and ENTV are members of a small family of exercise. Late stages of disease are often accompanied acutely transforming retroviruses in which an Env by the secretion of copious lung fluid that contains protein acts as an oncogene. infectious virus. Intriguingly, lung tumors induced by JSRV in sheep JSRV can induce lung tumors in newborn lambs in as morphologically resemble a subtype of human pulmonary little as 10 days following experimental inoculation adenocarcinomas previously referred to bronchiolo- (Verwoerd et al., 1980), showing that JSRV is an acutely alveolar carcinoma or BAC (Bonne, 1939). For exam- transforming retrovirus. However, JSRV is a simple ple, both OPA and BAC tumor cells express markers of retrovirus with no apparent oncogene present in its type II pneumocytes and Clara cells, and tumors are genome (Figure 1a). An alternate open reading frame, generally multifocal and localized to the periphery of the orf-X, which is present within the pol region of JSRV, lungs (Mornex et al., 2003). However, given the new was initially suspected to be an oncogenic factor but was definition of BAC by WHO (Travis et al., 1999), later excluded. Orf-X bears no resemblance to any important distinctions exist between OPA and BAC. known cellular oncogenes except sharing a weak BAC is now defined as a peripheral, well differentiated similarity with the adenosine A3 receptor (Bai et al., adenocarcinoma with pure bronchio-alveolar growth 1999). Disruption of orf-X has no effect on cell and no evidence of stromal, vascular and pleural transformation by JSRV (Maeda et al., 2001). Remark- invasion (Travis et al., 1999); while OPA is a mixed ably, expression of native JSRV Env protein alone is peripheral adenocarcinoma with acinar, papillary and sufficient to induce cell transformation in culture bronchio-alveolar growth (Palmarini and Fan, 2001). (Maeda et al., 2001; Rai et al., 2001; Allen et al., 2002; While the true frequency of pure BAC remains Danilkovitch-Miagkova et al., 2003; Liu and Miller, uncertain, tumors with histologically mixed BAC and 2005), indicating that Env is an active oncogene and is adenocarcinoma account for >20% all non-small cell likely to be the key factor in sheep oncogenesis. The only lung carcinomas (NSCLC) (Raz et al., 2006), and are other examples of retroviruses with oncogenic Env increasing in frequency (Barsky et al., 1994). proteins are ENTV (Alberti et al., 2002; Dirks et al., Similarities between OPA and human lung adenocar- 2002), a close relative of JSRV; avian hemangioma cinoma have led to the hypothesis that JSRV or a virus, which expresses an Env that induces proliferation related virus might be involved in human cancer. In one of monkey epithelial cells and NIH 3T3 cells (Alian study, antisera raised against the JSRV capsid protein et al., 2000); and spleen focus-forming virus, a replica- recognized B30% of human BAC and lung adenocar- tion-defective virus that expresses a recombinant non- cinoma samples but in general did not recognize other functional Env protein that induces cell proliferation in tumor types or normal lung tissue (De las Heras et al., cultured cells and in animals (Ruscetti, 1999). Therefore, 2000). In this case, PCR studies were not carried out to a JSRV Gag Pro Orf-X Env LTR Pol LTR 1 kb b JSRV Env SU TM SP MCT 0.3 kb c Env cytoplasmic tail (CT) 590 JSRV7 RGMVRDFLKMRVEMLHMKYRNMLQHQHLMELLKNKERGDAGD--D-P JSRV21 ............................................... JSRVSA ..L.................T....R............A...--.P. ENTV ..LIK...Q..I.LI.....Y...Y.K..DFV.KR.GSCG.QPAEG- ESRV .SI.KE..H...-LI.---K..................A...--.-. Figure 1 Schematic representations of JSRV genome, Env structure and sequence alignment of Env cytoplasmic tail. (a) JSRV is a simple retrovirus encoding Gag, Pol, Pro and Env that are flanked by the long term repeats (LTRs). An additional open reading frame X (Orf-X) is present within the Pol region with unknown function. (b) JSRV Env is type I transmembrane protein, with B620 amino acids in length. It is composed of two subunits, surface (SU) and transmembrane (TM). SP is signal peptide. M is membrane-spanning domain. CT is cytoplasmic tail. (c) Sequence alignment of JSRV Env cytoplasmic tail and in comparison with that of ENTV (Y16627) and endogenous sheep retrovirus. Note that a YXXM motif, the putative binding site for PI3K/p85, is conserved among all transforming JSRV and ENTV Env, but is absent in that of endogenous sheep retrovirus.
Load more

Recommended publications
  • Identification of Novel Genetic Variants Associated with Short Stature in A
    Human Genetics https://doi.org/10.1007/s00439-020-02191-x ORIGINAL INVESTIGATION Identifcation of novel genetic variants associated with short stature in a Baka Pygmies population Matteo Zoccolillo1 · Claudia Moia2 · Sergio Comincini2 · Davide Cittaro3 · Dejan Lazarevic3 · Karen A. Pisani1 · Jan M. Wit4 · Mauro Bozzola5 Received: 1 April 2020 / Accepted: 30 May 2020 © The Author(s) 2020 Abstract Human growth is a complex trait determined by genetic factors in combination with external stimuli, including environment, nutrition and hormonal status. In the past, several genome-wide association studies (GWAS) have collectively identifed hundreds of genetic variants having a putative efect on determining adult height in diferent worldwide populations. Theo- retically, a valuable approach to better understand the mechanisms of complex traits as adult height is to study a population exhibiting extreme stature phenotypes, such as African Baka Pygmies. After phenotypic characterization, we sequenced the whole exomes of a cohort of Baka Pygmies and their non-Pygmies Bantu neighbors to highlight genetic variants associated with the reduced stature. Whole exome data analysis revealed 29 single nucleotide polymorphisms (SNPs) signifcantly associated with the reduced height in the Baka group. Among these variants, we focused on SNP rs7629425, located in the 5′-UTR of the Hyaluronidase-2 (HYAL2) gene. The frequency of the alternative allele was signifcantly increased compared to African and non-African populations. In vitro luciferase assay showed signifcant diferences in transcription modulation by rs7629425 C/T alleles. In conclusion, our results suggested that the HYAL2 gene variants may play a role in the etiology of short stature in Baka Pygmies population.
    [Show full text]
  • Advances in the Study of Transmissible Respiratory Tumours in Small Ruminants Veterinary Microbiology
    Veterinary Microbiology 181 (2015) 170–177 Contents lists available at ScienceDirect Veterinary Microbiology journa l homepage: www.elsevier.com/locate/vetmic Advances in the study of transmissible respiratory tumours in small ruminants a a a a,b a, M. Monot , F. Archer , M. Gomes , J.-F. Mornex , C. Leroux * a INRA UMR754-Université Lyon 1, Retrovirus and Comparative Pathology, France; Université de Lyon, France b Hospices Civils de Lyon, France A R T I C L E I N F O A B S T R A C T Sheep and goats are widely infected by oncogenic retroviruses, namely Jaagsiekte Sheep RetroVirus (JSRV) Keywords: and Enzootic Nasal Tumour Virus (ENTV). Under field conditions, these viruses induce transformation of Cancer differentiated epithelial cells in the lungs for Jaagsiekte Sheep RetroVirus or the nasal cavities for Enzootic ENTV Nasal Tumour Virus. As in other vertebrates, a family of endogenous retroviruses named endogenous Goat JSRV Jaagsiekte Sheep RetroVirus (enJSRV) and closely related to exogenous Jaagsiekte Sheep RetroVirus is present Lepidic in domestic and wild small ruminants. Interestingly, Jaagsiekte Sheep RetroVirus and Enzootic Nasal Respiratory infection Tumour Virus are able to promote cell transformation, leading to cancer through their envelope Retrovirus glycoproteins. In vitro, it has been demonstrated that the envelope is able to deregulate some of the Sheep important signaling pathways that control cell proliferation. The role of the retroviral envelope in cell transformation has attracted considerable attention in the past years, but it appears to be highly dependent of the nature and origin of the cells used. Aside from its health impact in animals, it has been reported for many years that the Jaagsiekte Sheep RetroVirus-induced lung cancer is analogous to a rare, peculiar form of lung adenocarcinoma in humans, namely lepidic pulmonary adenocarcinoma.
    [Show full text]
  • HYAL2 Antibody (R30915)
    HYAL2 Antibody (R30915) Catalog No. Formulation Size R30915 0.5mg/ml if reconstituted with 0.2ml sterile DI water 100 ug Bulk quote request Availability 1-3 business days Species Reactivity Human, Mouse, Rat. Format Antigen affinity purified Clonality Polyclonal (rabbit origin) Isotype Rabbit IgG Purity Antigen affinity Buffer Lyophilized from 1X PBS with 2.5% BSA and 0.025% sodium azide/thimerosal UniProt Q12891 Applications Western blot : 0.5-1ug/ml Limitations This HYAL2 antibody is available for research use only. Western blot testing of HYAL2 antibody and Lane 1: HeLa; 2: SMMC-7721; 3: COLO320; 4: MCF-7; 5: HT1080 cell lysate Description Hyaluronoglucosaminidase 2, also known as hyaluronidase 2, and LuCa-2, is an enzyme that in humans is encoded by the HYAL2 gene. HYAL2 cDNAs encode a preprotein with an N-terminal signal peptide. Northern blot analysis indicated that the gene was expressed in all human tissues tested except adult brain, and Western blot analysis detected the protein in all mouse tissues examined except adult brain. HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored protein on the cell surface and serves as a receptor for entry into the cell of the jaagsiekte sheep retrovirus (JSRV). The findings of Rai et al.(2001) that HYAL2 is a GPI-anchored protein on the cell surface showed that GFP would likely be cleaved from HYAL2 during GPI addition, leaving HYAL2 on the cell surface and resulting in GFP transit to the lysosome for degradation. Application Notes The stated application concentrations are suggested starting amounts. Titration of the HYAL2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
    [Show full text]
  • 2007Murciaphd.Pdf
    https://theses.gla.ac.uk/ Theses Digitisation: https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ This is a digitised version of the original print thesis. Copyright and moral rights for this work are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This work cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Enlighten: Theses https://theses.gla.ac.uk/ [email protected] LATE RESTRICTION INDUCED BY AN ENDOGENOUS RETROVIRUS Pablo Ramiro Murcia August 2007 Thesis presented to the School of Veterinary Medicine at the University of Glasgow for the degree of Doctor of Philosophy Institute of Comparative Medicine 464 Bearsden Road Glasgow G61 IQH ©Pablo Murcia ProQuest Number: 10390741 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10390741 Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code Microform Edition © ProQuest LLO.
    [Show full text]
  • Molecular Basis, Diagnosis and Clinical Management Of
    cardio_special issue 2013_biomarin:Hrev_master 05/03/13 09.19 Pagina 2 Cardiogenetics 2013; 3(s1):exxxx3(s1):e2 Molecular basis, diagnosis storage of glycosaminoglycans (GAGs), previ- ously called mucopolysaccharides.1 The defi- Correspondence: Rossella Parini, Department of and clinical management of ciency of one of the enzymes participating in Pediatrics, San Gerardo Hospital, Via Pergolesi mucopolysaccharidoses the GAGs degradation pathway causes progres- 33, 20900 Monza, Italy. sive storage in the lysosomes and consequently Tel. +39.039.2333286 - Fax: +39.039.2334364. E-mail: [email protected] Rossella Parini,1 Francesca Bertola,2 in the cells and results in tissues and organs 3 Pierluigi Russo dysfunction. The damage is both direct or by Key words: mucopolysaccharidoses (MPS), heart, 1UOS Malattie Metaboliche Rare, activation of secondary and tertiary pathways heart and MPS, genetics and MPS. 2 Department of Pediatrics, Fondazione among which a role is played by inflammation. The incidence of MPSs as a group is reported Acknowledgments: RP and PR acknowledge MBBM, Azienda Ospedaliera San between 1:25000 and 1:45000.3 At present 11 dif- patients and their families and Drs. Andrea Gerardo, University of Milano-Bicocca; ferent enzyme deficiencies are involved in Imperatori and Lucia Boffi who collaborated in 2Consortium for Human Molecular the clinical cardiological evaluation of MPSs MPSs producing 7 distinct clinical phenotypes1 Genetics, University of Milano-Bicocca; patients. RP thanks Fondazione Pierfranco e (Table 1).4 Depending on the enzyme deficien- 3UO Department of Cardiology, Azienda Luisa Mariani of Milano for providing financial cy, the catabolism of dermatan sulphate, support for clinical assistance to metabolic Ospedaliera San Gerardo, Monza, Italy heparan sulphate, keratan sulphate, chon- patients and Mrs.
    [Show full text]
  • Genetic Deletions in Sputum As Diagnostic Markers for Early Detection of Stage I Non ^ Small Cell Lung Cancer Ruiyun Li,1Nevins W
    Imaging, Diagnosis, Prognosis Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non ^ Small Cell Lung Cancer Ruiyun Li,1Nevins W. Todd,2 Qi Qiu,3 Ta o F a n , 3 Richard Y. Zhao,3 William H. Rodgers,3 Hong-Bin Fang,4 Ruth L. Katz,5 Sanford A. Stass,3 and Feng Jiang3 Abstract Purpose: Analysis of molecular genetic markers in biological fluids has been proposed as a powerful tool for cancer diagnosis. We have characterized in detail the genetic signatures in primary non ^ small cell lung cancer, which provided potential diagnostic biomarkers for lung cancer. The aim of this study was to determine whether the genetic changes can be used as markers in sputum specimen for the early detection of lung cancer. Experimental Design: Genetic aberrations in the genes HYAL2, FHIT,andSFTPC were evalu- ated in paired tumors and sputum samples from 38 patients with stage I non ^ small cell lung cancer and in sputum samples from 36 cancer-free smokers and 28 healthy nonsmokers by using fluorescence in situ hybridization. Results: HYAL2 and FHIT weredeletedin84%and79%tumorsandin45%and40%paired sputum, respectively. SFTPC was deleted exclusively in tumor tissues (71%).There was concor- dance of HYAL2 or FHIT deletions in matched sputum and tumor tissues from lung cancer patients (r =0.82,P =0.04;r =0.84,P = 0.03), suggesting that the genetic changes in sputum might indicate the presence of the same genetic aberrations in lung tumors. Furthermore, abnor- mal cells were found in 76% sputum by detecting combined HYAL2 and FHIT deletions whereas in 47% sputum by cytology, of the cancer cases, implying that detecting the combination of HYAL2 and FHIT deletions had higher sensitivity than that of sputum cytology for lung cancer diagnosis.
    [Show full text]
  • Genome Sequencing Unveils a Regulatory Landscape of Platelet Reactivity
    ARTICLE https://doi.org/10.1038/s41467-021-23470-9 OPEN Genome sequencing unveils a regulatory landscape of platelet reactivity Ali R. Keramati 1,2,124, Ming-Huei Chen3,4,124, Benjamin A. T. Rodriguez3,4,5,124, Lisa R. Yanek 2,6, Arunoday Bhan7, Brady J. Gaynor 8,9, Kathleen Ryan8,9, Jennifer A. Brody 10, Xue Zhong11, Qiang Wei12, NHLBI Trans-Omics for Precision (TOPMed) Consortium*, Kai Kammers13, Kanika Kanchan14, Kruthika Iyer14, Madeline H. Kowalski15, Achilleas N. Pitsillides4,16, L. Adrienne Cupples 4,16, Bingshan Li 12, Thorsten M. Schlaeger7, Alan R. Shuldiner9, Jeffrey R. O’Connell8,9, Ingo Ruczinski17, Braxton D. Mitchell 8,9, ✉ Nauder Faraday2,18, Margaret A. Taub17, Lewis C. Becker1,2, Joshua P. Lewis 8,9,125 , 2,14,125✉ 3,4,125✉ 1234567890():,; Rasika A. Mathias & Andrew D. Johnson Platelet aggregation at the site of atherosclerotic vascular injury is the underlying patho- physiology of myocardial infarction and stroke. To build upon prior GWAS, here we report on 16 loci identified through a whole genome sequencing (WGS) approach in 3,855 NHLBI Trans-Omics for Precision Medicine (TOPMed) participants deeply phenotyped for platelet aggregation. We identify the RGS18 locus, which encodes a myeloerythroid lineage-specific regulator of G-protein signaling that co-localizes with expression quantitative trait loci (eQTL) signatures for RGS18 expression in platelets. Gene-based approaches implicate the SVEP1 gene, a known contributor of coronary artery disease risk. Sentinel variants at RGS18 and PEAR1 are associated with thrombosis risk and increased gastrointestinal bleeding risk, respectively. Our WGS findings add to previously identified GWAS loci, provide insights regarding the mechanism(s) by which genetics may influence cardiovascular disease risk, and underscore the importance of rare variant and regulatory approaches to identifying loci contributing to complex phenotypes.
    [Show full text]
  • Expression of Rous Sarcoma Virus-Derived Retroviral Vectors In
    Proc. Natl. Acad. Sci. USA Vol. 88, pp. 10505-10509, December 1991 Developmental Biology Expression of Rous sarcoma virus-derived retroviral vectors in the avian blastoderm: Potential as stable genetic markers (embryonic development/replication-defective virus/lineage marker/lacZ) SRINU T. REDDY, ANDREW W. STOKER, AND MINA J. BISSELL Division of Cell and Molecular Biology, Lawrence Berkeley Laboratory, 1 Cyclotron Road, Berkeley, CA 94720 Communicated by Melvin Calvin, August 26, 1991 ABSTRACT Retroviruses are valuable tools in studies of preliminary evidence that cultured chicken blastoderm cells embryonic development, both as gene expression vectors and as could express viral proteins upon RSV infection. Because the cell lineage markers. In this study early chicken blastoderm resolution of this question has important implications for the cells are shown to be permissive for infection by Rous sarcoma use of retroviruses in studies of early avian development, we virus and derivative replication-defective vectors, and, in con- have now addressed directly the permissivity of the chicken trast to previously published data, these cells will readily blastoderm toward viral expression. express viral genes. In cultured blastoderm cells, Rous sarcoma We have asked specifically whether or not a block to viral virus stably integrates and is transcribed efficiently, producing expression occurs in cultured cells isolated from chicken infectious virus particles. Using replication-defective vectors blastoderms, and whether replication-defective vectors can encoding the bacterial lacZ gene, we further show that blas- be used to mark cells genetically at the blastoderm stage in toderms can be infected in culture and in ovo. In ovo, lacZ ovo. Using cultured chicken blastoderm cells, we demon- expression is seen within 24 hr of virus inoculation, and by 96 strate that RSV not only infects and integrates but, in contrast hr stably expressing clones of cells are observed in diverse to previous data (15), is also expressed well in these cells.
    [Show full text]
  • Datasheet: 5030­9954
    Datasheet: 5030­9954 Description: NATIVE BOVINE HYALURONIDASE Name: HYALURONIDASE Format: Purified Product Type: Purified Protein Quantity: 0.5 g Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution ELISA Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls. Target Species Bovine Product Form Purified enzyme from bovine testes - liquid Preservative None present Stabilisers Approx. Protein Total protein concentration 0.2 g/ml Concentrations External Database UniProt: Links Q8SQG8 Related reagents Q5E985 Related reagents Entrez Gene: 281838 HYAL2 Related reagents 515397 HYAL1 Related reagents Product Information Hyaluronidase catalyzes the depolymerization of mucopolysaccharides, hyaluronic acid, and the chondroitin sulfates A and C. The enzyme is widely distributed in animal tissues but is found in great concentrations in the bovine and ovine testes. Molecular Weight MW: 55 kD Activity 315 U/mg protein 1 unit is defined as the amount of enzyme that liberates one micromole of N-acetylglucosamine Page 1 of 2 per minute at 37ºC and pH 4.0. EC 3.2.1.36 Storage Store at -20oC only.
    [Show full text]
  • Human Foamy Virus Integrase Fails to Catalyse the Integration of a Circular DNA Molecule Containing an LTR Junction Sequence
    Gene Therapy (2002) 9, 1326–1332 2002 Nature Publishing Group All rights reserved 0969-7128/02 $25.00 www.nature.com/gt BRIEF COMMUNICATION Human foamy virus integrase fails to catalyse the integration of a circular DNA molecule containing an LTR junction sequence RA Russell1, R Critchley2, G Vassaux2 and MO McClure1 1Jefferiss Research Trust Laboratories, Wright-Fleming Institute, Imperial College School of Medicine at St Mary’s Hospital, London, UK; and 2Molecular Therapy Laboratory, ICRF Molecular Oncology Unit, ICSM at Hammersmith Hospital, London, UK The presence of closed circular forms of the linear DNA gen- ing transfection of both 293 and 293T cells indicated that the ome of human foamy virus (HFV) has not been established. level of integration was not significantly increased by the The ability of the HFV integrase (IN) to catalyse the inte- HFV IN. Moreover, correctly integrated provirus-like forms gration of these circular forms (termed 2 long terminal repeat of the input plasmid could not be detected by PCR. Taken (LTR) circles) was investigated, with a view to producing a together, these results show that the HFV IN is not able to novel hybrid vector. To this end, a construct was made con- integrate a circular molecule containing an LTR junction and, taining, in addition to the enhanced green fluorescent protein hence, the technique is not exploitable as a tool to produce (eGFP) marker gene, the last 27 bp of the 3’ U5 LTR region hybrid vectors for gene therapy. of HFV fused to the first 28 bp of the 5’ U3 LTR, the latter Gene Therapy (2002) 9, 1326–1332.
    [Show full text]
  • The Discovery of HTLV-1, the First Pathogenic Human Retrovirus John M
    PERSPECTIVE PERSPECTIVE The discovery of HTLV-1, the first pathogenic human retrovirus John M. Coffin1 Tufts University School of Medicine, Boston MA 02111 Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA, and approved November 11, 2015 (received for review November 2, 2015) After the discovery of retroviral reverse transcriptase in 1970, there was a flurry of activity, sparked by the “War on Cancer,” to identify human cancer retroviruses. After many false claims resulting from various artifacts, most scientists abandoned the search, but the Gallo laboratory carried on, developing both specific assays and new cell culture methods that enabled them to report, in the accompanying 1980 PNAS paper, identification and partial characterization of human T-cell leukemia virus (HTLV; now known as HTLV-1) produced by a T-cell line from a lymphoma patient. Follow-up studies, including collaboration with the group that first identified a cluster of adult T-cell leukemia (ATL) cases in Japan, provided conclusive evidence that HTLV was the cause of this disease. HTLV-1 is now known to infect at least 4–10 million people worldwide, about 5% of whom will develop ATL. Despite intensive research, knowledge of the viral etiology has not led to improvement in treatment or outcome of ATL. However, the technology for discovery of HTLV and acknowledgment of the existence of pathogenic human retroviruses laid the technical and intellectual foundation for the discovery of the cause of AIDS soon afterward. Without this advance, our ability to diagnose and treat HIV infection most likely would have been long delayed.
    [Show full text]
  • Jaagsiekte Sheep Retrovirus (JSRV)
    Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep Caroline Leroux, Nicolas Girard, Vincent Cottin, Timothy Greenland, Jean-François Mornex, Fabienne Archer To cite this version: Caroline Leroux, Nicolas Girard, Vincent Cottin, Timothy Greenland, Jean-François Mornex, et al.. Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep. Veterinary Research, BioMed Central, 2007, 38 (2), pp.211-228. 10.1051/vetres:2006060. hal-00902865 HAL Id: hal-00902865 https://hal.archives-ouvertes.fr/hal-00902865 Submitted on 1 Jan 2007 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Copyright Vet. Res. 38 (2007) 211–228 211 c INRA, EDP Sciences, 2007 DOI: 10.1051/vetres:2006060 Review article Jaagsiekte Sheep Retrovirus (JSRV): from virus to lung cancer in sheep Caroline La*,NicolasGa, Vincent Ca,b, Timothy Ga, Jean-François Ma,b, Fabienne Aa a Université de Lyon 1, INRA, UMR754, École Nationale Vétérinaire de Lyon, IFR 128, F-69007, Lyon, France b Centre de référence des maladies orphelines pulmonaires, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France (Received 11 September 2006; accepted 23 November 2006) Abstract – Jaagsiekte Sheep Retrovirus (JSRV) is a betaretrovirus infecting sheep.
    [Show full text]